Skip to main content
Log in

Expression of hepatocyte growth factor (HGF) and its receptor (MET) in medullary carcinoma of the thyroid

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

The tyrosine kinase receptor encoded by the MET oncogene has the unusual property of mediating the invasive growth of epithelial cells upon binding with the hepatocyte growth factor (HGF). The MET/HGF receptor is known to be overexpressed in thyroid carcinomas originated from follicular cells, but has not been reported in C cell tumors. To investigate the role of HGF and of its receptor (encoded by MET oncogene) in medullary carcinoma of the thyroid (MCT), we studied the expression of HGF and MET in 20 cases by means of different techniques. By RT-PCR, HGF mRNA was found in 10/20 cases, while MET mRNA presence was demonstrated in 8/20, of which 7 also expressed HGF. Northern blot analysis and in situ hybridization were performed in selected cases and confirmed RT-PCR data in some cases, although the lower sensitivity of these procedures did not allow the identification of all RT-PCR positive cases. By immunohistochemistry (using specific monoclonal antibodies) HGF was demonstrated in 8/9 RT-PCR positive cases ald a monoclonal to MET immunostained 5/6 RT-PCR positive cases. All receptor positive cases also expressed the ligand in the same tumor cell population. These findings demonstrate MET and HGF co-expression in a subset of MCT, in which autocrine/paracrine circuits may be active. No correlation was found between HGF/MET expression and clinico-pathological parameters, except for the more common multifocality of HGF/MET positive MCT. Whether the potential activation of MET in MCT is responsible for local invasion and malignant evolution is to be further investigated, especially in multifocal and aggressive tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Suarez HG, duVillard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, et al. Presence of mutations of all three ras genes in human thyroid tumors. Oncogene 5:565–570, 1990.

    PubMed  CAS  Google Scholar 

  2. Pilotti S, Collini P, Rilke F, Cattoretti G, Delbo R, Pierotti M. bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337–342, 1994.

    Article  PubMed  CAS  Google Scholar 

  3. Pilotti S, Collini P, Delbo R, Cattoretti G, Pierotti MA, Rilke F. A novel panel of antibodies that segregates immunocyto hemically poorly differentiaced carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 18:1054–1064, 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Matias-Guiu X, Villanueva A, Cuatrecasas M, Capella G, DeLeiva A, Prat J. p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma. Path Res Pract 192:1242–1249, 1996.

    PubMed  CAS  Google Scholar 

  5. Fusco A, Grieco M, Santoro M, Berlingeri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio GC. A new oncogene in human thyroid papillary carcinomas and their lymphnodal metastases. Nature 328:170–172, 1987.

    Article  PubMed  CAS  Google Scholar 

  6. Grieco M, Santoro M, Berlingeri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, DellaPorta G, Fusco A, Vecchio GC. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557–563, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PhU. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary carcinomas. Cancer 76:479–89, 1995.

    Article  PubMed  CAS  Google Scholar 

  8. Naldini L, Vigna E, Narsimhan R, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 6:501–504, 1991.

    PubMed  CAS  Google Scholar 

  9. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, VandeWoude G. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29–33, 1984.

    Article  PubMed  CAS  Google Scholar 

  10. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, et al. Expression of the met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997–2003, 1991.

    PubMed  Google Scholar 

  11. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49:323–328, 1991.

    Article  PubMed  CAS  Google Scholar 

  12. Scotlandi K, Baldini N, Olivero M, DiRenzo MF, Martano M, Serra M, et al. Expression of MET/Hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Am J Pathol 149:1209–1219, 1996.

    PubMed  CAS  Google Scholar 

  13. Nabeshima K, Shimao Y, Sato S, Kataoka H, Horiyama T, Kawano H, et al. Expression of c-Met correlates with grade of malignancy in human astrocytic tumors: an immunohistochemical study. Histopathol 31:436–443, 1997.

    Article  CAS  Google Scholar 

  14. Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H, Tsuneyoshi M. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pthol 10:832–838, 1997.

    CAS  Google Scholar 

  15. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16:68–73, 1997.

    Article  PubMed  CAS  Google Scholar 

  16. Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, et al. A novel mutation in the ATP binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int. J. Cancer:82, 640–643, 1999

    Article  PubMed  CAS  Google Scholar 

  17. Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O, et al. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab 82:2322–2328, 1997.

    Article  PubMed  CAS  Google Scholar 

  18. Oyama T, Ichimura E, Sano T, Kashiwabara K, Fukuda T, Nakajiama T. c-Met expression of thyroid tissue with special reference to papillary carcinoma. Pathol Int 48:763–768, 1998.

    Article  PubMed  CAS  Google Scholar 

  19. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549–2553, 1992.

    PubMed  Google Scholar 

  20. Ruco LP, Ranalli T, Marzullo A, Bianco P, Prat M, Comoglio PM, Baroni C. Expression of Met protein in thyroid tumors. J Pathol 180:266–270, 1996.

    Article  PubMed  CAS  Google Scholar 

  21. Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, et al. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid 8:125–131, 1998.

    Article  PubMed  CAS  Google Scholar 

  22. Papotti M, Sambataro D, Pecchioni C, Bussolati G. The pathology of medullary carcinoma of the thyroid. Endocrine Pathol 7:1–20, 1996.

    Google Scholar 

  23. Albores-Saavedra J, Monforte H, Nadji M, Morales AR. C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19:795–799, 1988.

    Article  PubMed  CAS  Google Scholar 

  24. Chirgwin JM, Przybyla AE, McDonald RJ, Rutter WJ. Isolation of biologically active RNA from sourses enriched in ribonuclease. Biochemistry 18:5294–5297, 1979.

    Article  PubMed  CAS  Google Scholar 

  25. Ferraccini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1:739–749, 1995.

    Google Scholar 

  26. Papotti M, Pacchioni D, Negro F, Bonino F, Bussolati G. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Modern Pathol 7:271–275, 1994.

    CAS  Google Scholar 

  27. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the thyrosine kinase family of growth factor receptors. Proc Natl Acad Sci USA 84:6379–6383, 1987.

    Article  PubMed  CAS  Google Scholar 

  28. Sitzmann JH, LeMotte PK. Rapid and efficient generation of PCR-derived riboprobe templates for in situ hybridisation histochemistry. J Histochem Cytochem 41:773–776, 1993.

    PubMed  CAS  Google Scholar 

  29. DiRenzo MF, Poulson R, Olivero M, Comoglio PM, Lemoine NR. Expression of the Met/Hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55:1129–1138, 1995.

    CAS  Google Scholar 

  30. Zanetti A, Stoppacciaro A, Marzullo A, Ciabatta M, Fazioli F, Prat M, et al. Expression of MET protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol 186:287–291, 1998.

    Article  PubMed  CAS  Google Scholar 

  31. Bergstrom JD, Hermansson A, Diaz de Stahl T, Heldin NE. Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture. Br J Cancer 80:650–656, 1999.

    Article  PubMed  CAS  Google Scholar 

  32. Zarnegar R, Muga S, Enghild J, Michalopulos G. Tissue distribution of hepatopoietin A∶a heparin binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 87: 1252–1256, 1990.

    Article  PubMed  CAS  Google Scholar 

  33. Zarnegar R. Regulation of HGF and HGFR gene expression. EXS 74:33–49, 1995.

    PubMed  CAS  Google Scholar 

  34. Boccaccio C, Gaudino G, Gambarotta G, Galimi F, Comoglio PM. Hepatocyte growth factor (HGF) receptor expression in inducible and is part of the delayed-early response to HGF. J Biol Chem 269:12846–12851, 1994.

    PubMed  CAS  Google Scholar 

  35. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, Day ML. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147:386–396, 1995.

    PubMed  CAS  Google Scholar 

  36. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennechietti S, Nicotra MR, et al. Overexpression and activation of hepatocyte growth factor/scatter factor in human nonsmall-cell lung carcinomas. Br J Cancer 74:1862–1868, 1996.

    PubMed  CAS  Google Scholar 

  37. Ljubimova JY, Petrovic LM, Wilson SE, Geller SA, Demetriou AA. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem 45:79–87, 1997.

    PubMed  CAS  Google Scholar 

  38. Tuck AB, Park M, Sterns EE, Boag A, Elliott BE. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148:225–232, 1996.

    PubMed  CAS  Google Scholar 

  39. Tsao MS, Zhu H, Giaid A, Viallet J, Nakmura T, Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human bronchial epithelial and lung carcinoma cells. Cell Growth & Differ 4:571–579, 1993.

    CAS  Google Scholar 

  40. Wang Y, Selden AC, Morgan N, Stamp GWH, Hodgson HJF. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 144:675–682, 1994.

    PubMed  CAS  Google Scholar 

  41. Tamagnone L, Comoglio PM. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev 8:129–142, 1997.

    Article  PubMed  CAS  Google Scholar 

  42. Rao UNM, Sonmez-Alpan E, Michalopulos GK. Hepatocyte growth factor and c-Met in benign and malignant peripheral nerve sheath tumors. Hum Pathol 28:1066–1070, 1997.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papotti, M., Olivero, M., Volante, M. et al. Expression of hepatocyte growth factor (HGF) and its receptor (MET) in medullary carcinoma of the thyroid. Endocr Pathol 11, 19–30 (2000). https://doi.org/10.1385/EP:11:1:19

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:11:1:19

Key Words

Navigation